KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Capital Expenditures (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Capital Expenditures for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 13.96% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 billion through Dec 2025, up 9.22% year-over-year, with the annual reading at $4.8 billion for FY2025, 9.22% up from the prior year.
  • Capital Expenditures hit $1.8 billion in Q4 2025 for Johnson & Johnson, up from $1.2 billion in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.8 billion in Q4 2025 to a low of $607.0 million in Q2 2022.
  • Historically, Capital Expenditures has averaged $1.1 billion across 5 years, with a median of $1.0 billion in 2024.
  • Biggest five-year swings in Capital Expenditures: soared 42.17% in 2023 and later decreased 13.17% in 2024.
  • Year by year, Capital Expenditures stood at $747.0 million in 2021, then dropped by 18.74% to $607.0 million in 2022, then soared by 161.78% to $1.6 billion in 2023, then increased by 1.45% to $1.6 billion in 2024, then increased by 13.96% to $1.8 billion in 2025.
  • Business Quant data shows Capital Expenditures for JNJ at $1.8 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.0 billion in Q2 2025.